<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tblu25" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="top">Group 1</th><th valign="top">Group 2</th><th valign="top">Effect size <italic>d</italic></th><th valign="top">A priori power</th><th valign="top">Group 1 <break/>sample size</th><th valign="top">Group 2 <break/>sample size</th></tr></thead><tbody><tr><td valign="top">Untreated drug-na&#239;ve <break/>PC9 cells</td><td valign="top">50 nM TSA treated <break/>drug-na&#239;ve PC9 cells</td><td valign="top">0.85749<sup>1</sup></td><td valign="top">80.0%<sup>1</sup></td><td valign="top">3</td><td valign="top">3</td></tr><tr><td valign="top">Untreated drug-na&#239;ve <break/>PC9 cells</td><td valign="top">100 nM TSA treated <break/>drug-na&#239;ve PC9 cells</td><td valign="top">2.45967<sup>1</sup></td><td valign="top">80.0%<sup>1</sup></td><td valign="top">3</td><td valign="top">3</td></tr><tr><td valign="top">Untreated PC9 DTPs</td><td valign="top">50 nM TSA treated <break/>PC9 DTPs</td><td valign="top">11.30792</td><td valign="top">99.9%</td><td valign="top">3</td><td valign="top">3</td></tr><tr><td valign="top">Untreated PC9 DTPs</td><td valign="top">100 nM TSA treated <break/>PC9 DTPs</td><td valign="top">12.73512</td><td valign="top">86.8%<sup>2</sup></td><td valign="top">2<sup>2</sup></td><td valign="top">2<sup>2</sup></td></tr></tbody></table><table-wrap-foot><fn id="tblfn7"><p><sup>1</sup> A sensitivity calculation was performed since the original data showed a non-significant effect. This is the effect size that can be detected with 80% power and the indicated sample size.</p></fn><fn id="tblfn8"><p><sup>2</sup> 3 samples per group will be used based on the vehicle vs 50 nM TSA treated PC9 DTP comparison making the power 99.9%.</p></fn></table-wrap-foot></table-wrap>